A Phase I Study for the Evaluation of Safety and Efficacy of Humacyte's Human Acellular Vascular Graft for Use as a Vascular Prosthesis for Hemodialysis Access in Patients With End-Stage Renal Disease
Latest Information Update: 22 Aug 2022
At a glance
- Drugs Human acellular vessel-Humacyte (Primary)
- Indications Renal failure
- Focus Adverse reactions; Therapeutic Use
- Sponsors Humacyte
Most Recent Events
- 08 Oct 2021 New trial record